US redirecting 25 million dollar in aid for East Jerusalem hospitals Medical Dialogues Bureau10 Sept 2018 9:45 AM ISTWashington: The Trump administration said that it is cutting USD 25 million meant for East Jerusalem hospitals and putting the money toward...
Maryland charges Insys with engaging in deceptive opioid scheme Medical Dialogues Bureau10 Sept 2018 9:30 AM ISTMaryland charged Insys Therapeutics Inc with deceptively marketing a powerful opioid painkiller so that it was prescribed inappropriately beyond its...
USFDA completes inspection at Caplin Point Lab's sterile injectable facility in Tamil Nadu Medical Dialogues Bureau9 Sept 2018 10:45 AM ISTNew Delhi: Caplin Point Laboratories said the US health regulator has completed the inspection at its sterile injectable facility in Gummudipoondi in...
Fortis arm sells 15 lakh shares in RHT to Fortis Healthcare International Ltd Ruby Khatun Khatun9 Sept 2018 10:15 AM ISTNew Delhi: Fortis Healthcare said that its step-down subsidiary RHT Health Trust Manager has sold 15 lakh shares in RHT Health Trust to Fortis...
FDA approves Cassipa as maintenance treatment for opioid dependence Ruby Khatun Khatun9 Sept 2018 10:00 AM ISTThe U.S. Food and Drug Administration (FDA) approved Cassipa (buprenorphine and naloxone) sublingual film (applied under the tongue) for the...
AstraZeneca gets FDA breakthrough therapy label for asthma treatment Ruby Khatun Khatun9 Sept 2018 9:45 AM ISTAstraZeneca Plc and Amgen Inc said the U.S. Food and Drug Administration had granted a breakthrough therapy label for their drug to treat a type of...
Pfizer terminates Domagrozumab clinical studies for Duchenne muscular dystrophy Ruby Khatun Khatun9 Sept 2018 9:30 AM ISTNew York: Pfizer Inc. announced today that it is terminating two ongoing clinical studies evaluating domagrozumab (PF-06252616) for the treatment of...
Sun Pharma gets 6 observations by USFDA for its Halol facility Ruby Khatun Khatun8 Sept 2018 11:01 AM ISTNew Delhi: Drug major Sun Pharmaceutical Industries said the US health regulator has issued Form 483 with six observations after an inspection of its...
Johnson and Johnson says to work on India compensation for recalled hip implants Ruby Khatun Khatun8 Sept 2018 10:30 AM ISTMUMBAI: Johnson and Johnson said it would work with the Indian government to compensate patients who suffered from artificial hip implants the U.S....
Irdai ask insurers to provide 60-days grace period for health insurance premium Ruby Khatun Khatun8 Sept 2018 10:15 AM ISTNew Delhi: The insurance regulator Irdai Wednesday asked insurers to provide 60-days grace period for payment of health insurance premium in...
GSK says USFDA wants more information on pulmonary drug Medical Dialogues Bureau8 Sept 2018 9:45 AM ISTLONDON: GlaxoSmithKline (GSK) said that U.S. health authorities had asked for more information about its Nucala drug for use in combating chronic...
French drugmakers urge Brexit negotiators to safeguard supply chain Medical Dialogues Bureau8 Sept 2018 9:30 AM ISTFrench drugmakers are urging European and British negotiators ahead of a crunch Brexit meeting next month to ensure the free circulation of medicines...
